問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberNN8022-7780
NCT Number(ClinicalTrials.gov Identfier)-
Completed

2024-01-01 - 2025-12-31

Phase IV

Terminated11

-

  • Trial Applicant

    NOVO NORDISK PHARMA (TAIWAN) LTD.

  • Sponsor

    -

  • Trial scale

    Taiwan Multiple Center

  • Update

    2026/09/11

Investigators and Locations

Principal Investigator Wen-Yuan Lin Division of Family Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 鄔翔帆 Division of Pediatrics

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 杜思德 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 柯文清 Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 李純瑩 Division of Family Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 周莒光 Digestive System Department

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hai-Hua Chuang Division of Family Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 胡書瑋 Division of Pediatrics

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 王 偉

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Kuo-Chin Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    288 participants

  • Global

    288 participants